Hashim Mir 4

4 · Rani Therapeutics Holdings, Inc. · Filed Sep 13, 2021

Insider Transaction Report

Form 4
Period: 2021-09-09
Hashim Mir
Chief Scientific Officer
Transactions
  • Award

    Class A Common Stock

    2021-09-09+117,600117,600 total
Footnotes (1)
  • [F1]The shares subject to the restricted stock unit grant vest as follows: 50% of the RSUs shall vest on September 9, 2022, and 50% shall vest on September 9, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION